Advanced in Ventricular Septal Defects

Dr. David Overman

Thoracic Surgery
The Children's Heart Clinic
2530 Chicago Ave Ste 500, 
Minneapolis, MN 
Advanced in Ventricular Septal Defects
The Children's Heart Clinic
2530 Chicago Ave Ste 500, 
Minneapolis, MN 
OverviewInsuranceLocationsClinical Research

Overview

David Overman is a Thoracic Surgeon in Minneapolis, Minnesota. Dr. Overman is rated as an Advanced provider by MediFind in the treatment of Ventricular Septal Defects. His top areas of expertise are Atrioventricular Septal Defect, Congenital Heart Disease (CHD), Ebstein's Anomaly, and Hypoplastic Left Heart Syndrome (HLHS).

His clinical research consists of co-authoring 117 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Ventricular Septal Defects.

Specialties
Thoracic Surgery
Licenses
Internal Medicine in MN
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Sanford Health
  • HMO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 1 Less Insurance Carrier -

Locations

The Children's Heart Clinic
2530 Chicago Ave Ste 500, Minneapolis, MN 55404
Other Locations
Office
2525 Chicago Ave Ste 500, Minneapolis, MN 55404

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Phase IIb Study of Intramyocardial Injection of Autologous Umbilical Cord Blood Derived Mononuclear Cells During Stage II Surgical Repair of Right Ventricular Dependent Variants of Hypoplastic Left Heart Syndrome (AutoCell-S2)
Phase IIb Study of Intramyocardial Injection of Autologous Umbilical Cord Blood Derived Mononuclear Cells During Stage II Surgical Repair of Right Ventricular Dependent Variants of Hypoplastic Left Heart Syndrome (AutoCell-S2)
Enrollment Status: Active_not_recruiting
Publish Date: July 08, 2025
Intervention Type: Biological, Procedure
Study Drug: Autologous (Self) Mononuclear Cells Derived from Umbilical Cord Blood
Study Phase: Phase 2
A Single Arm, Non-randomized, Multi-center Clinical Study of the SJM Masters HP 15mm Rotatable Mechanical Heart Valve as Aortic Valve Replacement Therapy
A Single Arm, Non-randomized, Multi-center Clinical Study of the SJM Masters HP 15mm Rotatable Mechanical Heart Valve as Aortic Valve Replacement Therapy
Enrollment Status: Active_not_recruiting
Publish Date: February 11, 2025
Intervention Type: Device
HALO Clinical Study: A Single Arm, Prospective, Non-randomized, Multi Center Investigation of the SJM™ Masters HP™ 15mm Rotatable Mechanical Heart Valve
HALO Clinical Study: A Single Arm, Prospective, Non-randomized, Multi Center Investigation of the SJM™ Masters HP™ 15mm Rotatable Mechanical Heart Valve
Enrollment Status: Completed
Publish Date: February 11, 2025
Intervention Type: Device
Study Phase: Not Applicable
STeroids to REduce Systemic Inflammation After Infant Heart Surgery (STRESS)
STeroids to REduce Systemic Inflammation After Infant Heart Surgery (STRESS)
Enrollment Status: Completed
Publish Date: May 10, 2023
Intervention Type: Drug
Study Drug: Methylprednisolone
Study Phase: Phase 3
Phase I Safety Study of Autologous Umbilical Cord Blood Derived Mononuclear Cells During Surgical Stage II Palliation of Hypoplastic Left Heart Syndrome
Phase I Safety Study of Autologous Umbilical Cord Blood Derived Mononuclear Cells During Surgical Stage II Palliation of Hypoplastic Left Heart Syndrome
Enrollment Status: Completed
Publish Date: April 29, 2022
Intervention Type: Biological
Study Drug:  Autologous umbilical cord blood cells
Study Phase: Phase 1
Neurally Adjusted Ventilatory Assist (NAVA) Versus Conventional Biphasic Positive End Expiratory Pressure (BiPAP) Non-Invasive Respiratory Support in Infants Following Congenital Heart Surgery
Neurally Adjusted Ventilatory Assist (NAVA) Versus Conventional Biphasic Positive End Expiratory Pressure (BiPAP) Non-Invasive Respiratory Support in Infants Following Congenital Heart Surgery
Enrollment Status: Terminated
Publish Date: March 10, 2020
Intervention Type: Device
Study Phase: Not Applicable
View 5 Less Clinical Trials

117 Total Publications

Adjustment for Case Mix in Congenital Heart Surgery: The Role of Procedure Specific Factors.
Adjustment for Case Mix in Congenital Heart Surgery: The Role of Procedure Specific Factors.
Journal: The Annals of thoracic surgery
Published: October 20, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Overman's expertise for a condition
ConditionClose
    View All 14 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile